Board meeting held today on 14th November, 2025 to consider and approve the Unaudited Standalone and consolidated Financial Statement for the quarter and half year ended September 30, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hipolin Ltd's board approved unaudited Q2 and H1 FY26 results on November 14, 2025, with the statutory auditor issuing an unmodified review report. Standalone revenue from operations for Q2 was Rs 318.08 lacs (vs Rs 326.58 lacs in Q2 FY25), while H1 revenue declined to Rs 552.36 lacs from Rs 644.66 lacs, a drop of around 14%. The company returned to a marginal Q2 profit of Rs 0.46 lac versus a Rs 73.58 lac loss a year ago, but on a half-year basis still posted a net loss of Rs 38.44 lacs (narrowed from Rs 73.12 lacs). Consolidated numbers were largely similar. Borrowings reduced sharply to Rs 101.84 lacs from Rs 212.03 lacs, and the company earlier sold immovable property (land and factory building at Sanand) in Q1.
Shareholders see modest improvement — Q2 swung from loss to a tiny profit and half-year losses narrowed significantly, but top-line revenue continues to shrink, and the company remains loss-making on a half-year basis. Near-term outlook is mixed; no major positive catalyst from these numbers.